Michael Weiss is Chairman, Chief Executive Officer and President of TG Therapeutics, Inc. (TGTX). The company reported total compensation of $25,571,250 for fiscal year 2025.
| Salary | $875,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $23,550,000 |
| Option awards | $0 |
| Non-equity incentive plan | $1,146,250 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $0 |
| Total | $25,571,250 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure TG Therapeutics, Inc. filed April 30, 2026, accession 0001437749-26-014233.
| Peer-group chief executive median | $13,350,777 |
|---|---|
| Difference from that median | $12,220,473 |
| Percentile within the disclosed peer group | 99th |
| Peers with a disclosed figure | 17 |
Medians and percentiles are computed across the peer group TG Therapeutics, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Michael Weiss this page | Chairman, Chief Executive Officer and President | $25,571,250 |
| Sean Power | Chief Financial Officer, Treasurer and Corporate Secretary | $3,768,375 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full TG Therapeutics, Inc. compensation brief.
Michael Weiss's compensation sits inside TG Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.